Type 2 Diabetes Mellitus Completed Phase 4 Trials for Insulin Aspart (DB01306)

Also known as: Diabetes Mellitus Non-insulin-dependent / Type-2 Diabetes Mellitus / Diabetes Mellitus Type 2 (T2DM) / Diabetes Mellitus Type-2 / Type 2 Diabetes (T2DM) / Diabetes, Type 2 / Diabetes Mellitus, Type 2 (T2DM) / Diabetes Mellitus,Type 2 / Diabetes Type II / Type-II Diabetes Mellitus / Diabetes Mellitus 2 Type / T2DM / Diabetes Mellitus Type II / Type II Diabetes / Diabetes Mellitus, Type 2 / Type 2 Diabetes Mellitus (T2DM) / Diabetes Type Two / Diabetes Mellitus - Type 2 / Diabetes, Type II / Non-Insulin-Dependent Diabetes Mellitus / Diabetes Mellitus. Type 2 / Diabetes Type 2 / Type 2 Diabetes Mellitus (T2D) / Type 2 Diabetes (T2D) / Type II; Diabetes / Type II Diabetes Mellitus / Diabetes Mellitus, Type II / NIDDM / Type-2 Diabetes / Type 2 Diabetes Mellitus(T2DM) / Type 2 Diabetes / Type 2-diabetes / Noninsulin Dependent Diabetes Mellitus, Type II / Diabetes Mellitus Type 2 / Type Two Diabetes Mellitus / T2DM (Type 2 Diabetes Mellitus) / Type-2-diabetes Mellitus / Diabetes mellitus -adult onset / Diabetes mellitus non insulin-dep / Maturity onset diabetes / Diabetes mellitus maturity onset

IndicationStatusPhase
DBCOND0029752 (Type 2 Diabetes Mellitus)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00590226Insulin Detemir Versus NPH Insulin In Hospitalized Patients With DiabetesTreatment
NCT00657943The Copenhagen Insulin and Metformin Therapy TrialTreatment
NCT01293396Comparison of Premixed Insulins Aspart 30, Aspart 70 and Aspart on Postprandial LipidsTreatment
NCT00121966South Danish Diabetes Study: Evaluation of the Antidiabetic Treatment of Type 2 Diabetes MellitusTreatment
NCT00467649A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 DiabetesTreatment
NCT00771693Effects of Insulin Treatment on Postprandial Platelet Activation in Patients With Non-insulin-dependent Diabetes Mellitus (NIDDM)Basic Science
NCT00821795Veterans Inpatient Insulin Study and Transition to Outpatient TherapyTreatment
NCT02453685A Study to Compare Insulin Intensification of Biphasic Insulin Aspart 30 and Insulin Analogues (Insulin Glargine and Insulin Aspart) in Insulin naïve Type 2 Diabetic PatientsTreatment
NCT01966978The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE StudyTreatment
NCT00494988Self-control Trial to Evaluate the Remission Rate in Newly Diagnosed Type 2 Diabetes Patients After Treatment With Insulin AspartTreatment
NCT00384085Insulin Glargine All to Target TrialTreatment
NCT00965549Comparison of a Basal Plus One Insulin Regimen With a Biphasic Insulin Regimen in Type 2 Diabetes PatientsTreatment
NCT00537303Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 DiabetesTreatment
NCT00537277Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes Mellitus When Failing on OADsTreatment
NCT00593255Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 DiabetesTreatment
NCT01490112Surveillance Study of NovoRapid® for New Drug Re-examination
NCT00619697Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 DiabetesTreatment
NCT00572806Initiation of Insulin Aspart in Type 2 DiabetesTreatment
NCT00791895Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADsTreatment
NCT00676819Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 DiabetesTreatment
NCT01697631Glycemic Control of Biphasic Insulin Aspart 30 in Type 2 DiabetesTreatment
NCT00669864Effect of Biphasic Insulin Aspart 30 Combined With Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes Inadequately Controlled With Basal InsulinTreatment
NCT01649570Safety and Efficacy of Insulin Aspart in Type 2 DiabetesTreatment
NCT00282451Effect of Biphasic Insulin Compared to Biphasic Insulin Combined With Insulin Aspart, With or Without Metformin in Type 2 DiabetesTreatment
NCT00274274Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 DiabetesTreatment
NCT00095446NovoLog Observation Trial in Subjects With Type 1 and Type 2 DiabetesDiagnostic
NCT01068652Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic DrugsTreatment
NCT00665093Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes
NCT00600366Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 DiabetesTreatment
NCT01165684Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus RegimenTreatment
NCT01212913Comparison of Insulin Glargine/Insulin Glulisine Regimen to Insulin Aspart/Insulin Aspart Protamine 30/70 in Type 2 Diabetes Mellitus Patients (T2DM)Treatment
NCT01889095Biphasic Insulin Aspart Versus NPH Plus Regular Human Insulin in Type 2 Diabetic PatientsTreatment
NCT01654120Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II DiabeticsTreatment